The effect of hydroxyurea therapy in Bahraini sickle cell disease patients
DK Shome, A Al Ajmi, AA Radhi, EJ Mansoor… - Indian Journal of …, 2016 - Springer
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
[PDF][PDF] The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi… - Indian J Hematol …, 2015 - researchgate.net
Hydroxyurea (HU) is used as a diseasemodifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
[HTML][HTML] The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi… - Indian Journal of …, 2016 - ncbi.nlm.nih.gov
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi… - Indian Journal of …, 2016 - search.proquest.com
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients.
DK Shome, A Al Ajmi, AA Radhi… - Indian Journal of …, 2015 - europepmc.org
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi, EJ Mansoor… - Indian Journal of …, 2016 - infona.pl
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
[PDF][PDF] The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi… - Indian J Hematol …, 2015 - academia.edu
Hydroxyurea (HU) is used as a diseasemodifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi… - Indian journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients.
DK Shome, A Al Ajmi, AA Radhi… - Indian Journal of …, 2015 - europepmc.org
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
[PDF][PDF] The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
DK Shome, A Al Ajmi, AA Radhi… - Indian J Hematol …, 2015 - academia.edu
Hydroxyurea (HU) is used as a diseasemodifying agent in sickle cell disease (SCD). Its
beneficial effects have been ascribed to inhibition of the sickling process through increase of …
beneficial effects have been ascribed to inhibition of the sickling process through increase of …